Hiring?
Logo

Eadie Technologies Inc.

location_on

Nova Scotia, Canada

Short Summary

Eadie Technologies Inc. has developed a new gold standard system for glaucoma diagnosis and monitoring; previously raised $500K with 10 ophthalmologist investors; optical & mechanical designs complete; prototype complete; patent filed; MVP by fall.

Overview

Target
480'000CHF
Minimum
6'900CHF
Investment Raised
69'000CHF
Previous Rounds CHF340,000
Stage Pre-Startup/R&D
Investor Role Any

Highlights

  • Seeking an exit in 4-5 years to strategic at $80-$100mn valuation
  • The company already has 10 ophthalmologists angel investors
  • High margin revenues are near-term with sales starting in late 2021
  • High growth market opportunity to displace existing devices
  • Prototype validated; minimum viable product complete in 4 months
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Global Pro
6% raised

Let's go to Africa !!!

location_on Quebec, Canada

We sell equipment and various technologies for medical applications to African governments with huge needs. We currently have a firm order of US$ 5.9M, the receivables of which are already insured by EDC. Also, we have for US$ 45M P.O coming up.

1'000'000 CHF

Target

69'000 CHF

Min per Investor

Global Pro
0% raised

TERRY2 Band

location_on Quebec, Canada

Using the radial artery (tiny artery from the wrist) is increasingly used to perform per-cutaneous diagnostic angiography or intervention (balloon angioplasty/stent implantation). One caveat is the risk of radial artery occlusion (RAO) post-procedure

130'000 CHF

Target

17'000 CHF

Min per Investor

0% raised

BT Neuro-MedWare

location_on Alberta, Canada

We are building software to allow people paralyzed due to spinal injury regain organic movements without unnatural/inconvenient interventions.

240'000 CHF

Target

3'400 CHF

Min per Investor

load one similar proposal

This website uses cookies to personalize and deliver appropriate content, analyze website traffic and display advertising. By clicking "Accept" you agree to our terms and may continue to use this website. Visit our cookie policy to learn more. ×